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Background: The risk of case-fatality following hospitalisation for asthma has not been well
characterised. We describe trends in 30 day case-fatality following hospitalisation for asthma
in adults in Scotland from 1981 to 2009.
Methods: Using the Scottish Morbidity Record Scheme (SMR01) with all asthma hospitalisations
for adults (18 years) with ICD9 493 and ICD10 J45eJ46 in the principal diagnostic position at
discharge (1981e2009). These data were linked to mortality data from the General Register
Office for Scotland (GROS), with asthma case-fatality defined as death within 30 days of
asthma admission (in or out of hospital). Logistic regression was used to explore the impact
of age, sex, previous asthma admission (in the 12 months prior to hospitalisation), socioeco-
nomic deprivation, year of admission and co-morbidity on 30-day case-fatality.
Results: There were a total of 116 457 asthma hospitalisations; a total of 1000 (0.9%) hospita-
lisations resulted in a post-admission death (within 30 days of admission). Odds ratios for un-
adjusted and adjusted case-fatality showed a decreased risk of case-fatality from the mid-
1990s onwards when compared to case-fatality in 1981. Advancing age and co-morbid diagno-
ses of respiratory failure, cancer, renal failure, cor pulmonale, coronary heart disease and res-
piratory infection were associated with increased likelihood of death.
Conclusions: 30 day case-fatality has declined over the last three decades, comparable tou.ac.uk (N.J. Roberts).
3 Elsevier Ltd. All rights reserved.
13.04.004
Time trends in 30 day case-fatality following asthma hospitalisation 1173case-fatality reported in other parts of the UK. This decline may be in part due to improved
guidelines, protocols and disease management for asthma over the last 30 years. The likeli-
hood of death 30 days following an asthma admission increased with age group and was asso-
ciated with respiratory failure, renal failure and cancer.
ª 2013 Elsevier Ltd. All rights reserved.Background
Asthma affects approximately 300 million people world-
wide.1 In 2007 the World Health Organisation estimated
that there were 250 000 asthma-related deaths per year.2
Compared to other chronic diseases asthma can be
considered to have a low mortality risk. Improvement in
clinical management and the advent of inhaled cortico-
steroids have improved asthma control and reduced
morbidity and mortality. Asthma mortality has declined
over the last two decades in most developed nations.3e5
Mackay et al. in Scotland showed stable mortality in the
5e44 age group for both males and females in the 1970s and
80s6 and Campbell et al. showed that since the late 1980s
asthma mortality has dropped (except for those over 85) in
England and Wales.7 Some studies have shown an increased
risk of mortality in asthma patients despite the overall
decline in asthma mortality.8,9
Watson et al.10 examined the mortality rate of 250 043
asthma admissions and examined the mortality levels after
admission (0.43%). Women and those aged over 45 had the
highest levels of mortality. Patients with severe asthma
account for the majority of asthma hospitalisations11 and
asthma severity has been shown to be the strongest inde-
pendent risk factor for hospital readmission.12 Severe
asthma is a significant burden to patients in terms of
morbidity and potential mortality, as well as being a
financial burden to the health service, in terms of cost from
managing hospitalisations of severe exacerbations.
It is generally accepted that asthma mortality rates are
generally much lower in well-designed clinical studies where
patients are monitored more meticulously than in routine
care. There is little published literature about current case-
fatality after an admission for asthma and it is important to
know mortality rates among severe asthmatics in routine
practice, and the case-fatality for asthma patients admitted
to hospital with an exacerbation. Patients with inadequately
controlled unstable severe asthma are at a higher risk of
exacerbation, as well as hospitalisation and mortality.13,14
This study describes trends in short-term case-fatality
following hospitalisation for asthma in adults in Scotland
from 1981 through to 2009.
Methods
The National Health Service (NHS) provides virtually all
elective and emergency hospital care in Scotland free at
point of access. Hospital discharge data are routinely
recorded in the Scottish Morbidity Record (SMR01). Up to six
discharge diagnoses, one principal and five co-morbid, are
recorded using the International Classification of Diseases
(ICD) system in SMR01 at the time of discharge. SMR01 dataare routinely linked to mortality records collected by the
General Registry Office for Scotland (GROS). We identified
all hospitalisations in adults (18 years of age) in which
asthma was coded in the principal diagnostic position at
discharge (ICD9 493; ICD10 J45eJ46) from 1st January 1981
to 31st December 2009.15
From the SMR01 dataset explanatory variables were
collected including demographic characteristics such as age,
sex, and co-morbidities. Age was grouped into the following
categories for analysis (18e24 years, 25e34 years, 35e44
years, 45e54 years, 55e64 years, and 65 years and over). Co-
morbid diagnoses were identified from secondary diagnoses
recorded during the index asthma hospitalisation, and prin-
cipal or secondary diagnoses during all prior hospitalisation in
the 5 years preceding the index asthma hospitalisation. Co-
morbid diagnoses included diabetes, cancer, coronary heart
disease, essential hypertension, cerebrovascular disease,
renal failure, respiratory infections, cor pulmonale, and
respiratory failure. Asthma hospitalisations within 12 months
of the index asthma hospitalisation were identified. Socio-
economic deprivation was defined using the CarstairseMorris
index of deprivation,16 an area-based measure based on
postcode sector of residence.
Statistical analysis
All subjects were followed from the date of hospital
admission for 30 days. Crude case-fatality at 30 days (from
date of admission) was calculated. Logistic regression was
used to model case-fatality at 30 days and explore the
impact of age group, sex, asthma hospitalisation within 12
months of the index asthma hospitalisation, socioeconomic
deprivation, year of hospitalisation and co-morbidity. To
account for the fact that one individual might contribute
multiple hospitalisations; the logistic regression was per-
formed specifying clustering at patient level to ensure
appropriate estimation of standard errors. The dataset was
examined for interactions between sex, age and comor-
bidities. The data were analysed for the association of
cohort, age and period with mortality, using the intrinsic
estimator approach17; the model presented is the best
fitting model. A significance level of 0.05 was used
throughout. Analyses were conducted using STATA (Version
10; STATA Corp, College Station, Texas).
Results
Baseline characteristics of patients hospitalised
with asthma (n Z 116 457)
There were 116 457 admissions for asthma during the study
period, there were significantly more women (76 198,
1174 N.J. Roberts et al.65.4%) admitted for asthma compared with men (40 259,
34.6%). The baseline characteristics of the cohort are out-
lined in Table 1. The mean (SD) age at admission was
46  18 years, and a quarter were in the most socioeco-
nomically deprived group.
Baseline characteristics according to vital status at
30 days (n Z 115 457)
Ninety-nine percent of the admissions were alive after 30
days of a hospital admission. The mean (SD) age at admission
was 46  18 years, with similar proportions of males and fe-
males compared with those who died within 30 days. The
most commonly associatedco-morbidities for thosewhowere
still alive after 30 days were respiratory infections (15.1%),
coronary heart disease (12.1%), essential hypertension
(6.7%), diabetes (4.5%) and respiratory failure (2.4%).
Crude case-fatality within 30 days of a hospital
admission for asthma (n Z 1000)
Overall crude case-fatality at 30 days was 0.9% (nZ 1000).
Those who died within 30 days of admission were older
(66  15.6 years). The likelihood of fatality increased with
increasing age group. Just over 60% of the case fatalities
were aged over 65 years. The most commonly associated
co-morbidities for all case fatalities were coronary heart
disease (35.9%), respiratory infections (23.2%), respiratory
failure (11.6%) and essential hypertension (9.4%).Table 1 Baseline characteristics of all asthma admissions.
All asthm
All N Z
Mean age at admission, year (SD) 45.9 (18
Age groups, N (%)
18e24 years 17 173
25e34 years 20 785
35e44 years 20 390
45e54 years 19 856
55e64 years 16 474
65 þ years þ 21 779
CarstairseMorris index of socioeconomic deprivation, N (%)
1st quintile (least deprived) 13 356
2nd quintile 16 573
3rd quintile 20 029
4th quintile 22 878
Quintile (most deprived) 29 871
Asthma hospitalisation in last 12 months N (%) 35 624
Comorbidity, N (%)
Diabetes 5289 (4.
Cancer 2231 (1.
Coronary heart disease 14 579 (
Essential hypertension 7837 (6.
Cerebrovascular disease 1955 (1.
Renal failure 999 (0.9
Respiratory infections 17 672 (
Cor pulmonale 567 (0.5
Respiratory failure 2941 (2.Adjusted case-fatality at 30 days
Table 2 shows the results from the logistic model with un-
adjusted and adjusted odds ratios (adjusted for age, sex,
year, socioeconomic deprivation and comorbidities). The
odds of mortality 30 days post-admission increased with
advancing age group. Co-morbid diagnoses of respiratory
failure, cancer, renal failure, cor pulmonale, coronary
heart disease and respiratory infection were associated
with an increased odds of mortality at 30 days.
On testing, the only statistically significant interactions
werebetween sex and co-morbid respiratory infections. Here
the adjusted odds ratio (OR) for case-fatality within 30 days
(respiratory infections vs no respiratory infections) was 1.75
(95% CI 1.35e2.27) forwomenand 1.08 (95%CI 0.75e1.56) for
men. Fig. 1 shows unadjusted and adjusted odds ratios for
each year of the study period. The overall trend was towards
a decline in the odds of 30 day case-fatality from the mid-
1990s relative to the start of the study period, although the
95% confidence intervals crossed unity indicating that the
difference was not statistically significant.
Discussion
Comparisons of hospital mortality rates are commonly
based on either in-hospital deaths18,19 or deaths that occur
within a fixed time period such as 30 days after admis-
sion.20,21 In-hospital deaths can be easily identified from
hospital discharge records, but may be subject to bias duea admissions
116 457 Men N Z 40 259 Women N Z 76 198
.32) 46.0(17.8) 45.9 (18.6)
5686 11 487
7163 13 622
6851 13 539
6996 12 860
6296 10 178
7267 14 512
4549 8807
5692 10 881
6613 13 416
7756 15 122
10 051 19 820
11 733 23 891
5) 1511 (3.8) 3778 (5.0)
9) 910 (2.3) 1321 (1.7)
12.5) 5377 (13.4) 9202 (12.1)
7) 2100 (5.2) 5737 (7.5)
7) 572 (1.4) 1383 (1.8)
) 348(0.9) 651(0.9)
15.2) 5571 (13.8) 12 101 (15.9)
) 262 (0.7) 305 (0.4)
5) 987 (2.4) 1954 (2.6)
Table 2 Logistic regression models for 30 day case-fatality after asthma admission (adjusted for age group, sex, year so-
cioeconomic deprivation, comorbidities).a
Unadjusted
odds ratio
Lower 95% CI,
upper 95% CI
Adjusted
odds ratio
Lower 95% CI,
upper 95% CI
Age group 18e24 1.0 (reference) 1.0 (reference)
Age group 25e34 1.0 0.5, 1.8 1.1 0.6, 2.2
Age group 35e44 1.4 0.8, 2.5 1.4 0.7, 2.7
Age group 45e54 3.1 1.8, 5.2 2.4 1.3, 4.4
Age group 55e64 8.9 5.4, 14.6 6.3 3.6, 11.1
Age group 65þ 19.6 12.1, 31.8 12.3 7.1, 21.3
Sex 0.8 0.71, 0.9 0.9 0.8, 1.0
CarstairseMorris index of Socioeconomic deprivation
1st quintile (least deprived) 1.0 (reference) 1.0 (reference)
2nd quintile 1.3 0.2, 1.7 1.4 1.1, 1.9
3rd quintile 1.1 0.2, 1.4 1.3 1.0, 1.8
4th quintile 0.9 0.1, 1.2 1.1 0.8, 1.4
5th quintile (most deprived) 1.0 0.1, 1.2 1.1 0.9, 1.5
Emergency admission 0.9 0.7, 1.1 1.2 0.9, 1.6
Asthma hospitalisation in last 12 months 0.9 0.7, 1.0 0.9 0.8, 1.1
Comorbidity
Diabetes 2.1 1.6, 2.6 1.1 0.8, 1.5
Cancer 5.2 4.1, 6.6 2.6 2.0, 3.5
Coronary heart disease 4.1 3.6, 4.7 1.6 1.4, 2.0
Essential hypertension 1.4 1.2, 1.8 0.8 0.6, 1.0
Cerebrovascular disease 3.8 2.9, 4.9 1.5 1.0, 2.1
Renal failure 5.9 4.3, 8.2 2.5 1.7, 3.9
Respiratory infections 1.7 1.5, 2.0 1.5 1.1, 1.8
Cor pulmonale 8.3 5.7, 12.3 1.9 1.1, 3.2
Respiratory failure 5.2 4.2, 6.6 4.0 3.0, 5.3
a The reference group consisted of men, aged 18e24 in deprivation quintile 1 (least deprived) in 1981, not an emergency admission and
no comorbidities.
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practices.22
This study set out to investigate mortality rates for
adults in Scotland, after a hospitalisation for asthma, from
1981 to 2009. There is little recent population data pub-
lished on case-fatality after an admission for asthma.
Published clinical studies generally have a high level of
patient monitoring and such studies report asthma mor-
tality rates, which are very low.
We found that asthma deaths in adults occurred at a low
rate; one thousand case fatalities were identified from
116 457 hospital admissions over three decades. Most of the
case fatalities were associated with individuals aged over 65
and this was strongly associated with comorbidities such as
respiratory and renal failure, and respiratory infections. It is
important for respiratory teams to manage other co-morbid
diagnoses as well as optimising care for asthma, for example,
ensuring provision of seasonal vaccination for those with se-
vere disease. These admissions were similar in terms of ages
and sex and comorbidities, and there was no effect of pre-
vious asthma admission. The logistic regressions showed that
increasing age group increased likelihood of mortality, and
there were no differences in mortality between men and
women. Other comorbidities, such as cancer and cor pulmo-
nale, were shown to increase the likelihood of case-fatality.
An American study using the nationwide inpatient sam-
ple by Krishnan et al.23 reported in-hospital asthma fatalityas 0.5%. In our dataset, asthma fatality was 0.9% at 30 days
from date of hospital admission. A study in Spain and Latin
America by Rodrigo et al.24 found levels of mortality
approximately 1% and a reduction in in-hospital mortality
over the study period (1.0% in 1994 to 0.7% in 2004). The
mean (SD) length of stay for those admitted was 7.5  5.7
days. In this study, deaths occurred more frequently in
those aged over 50, however multivariate analysis showed
that respiratory failure and respiratory infections were
independently associated with a significantly increased
mortality risk. Our study investigated case-fatality within
30 days following an asthma admission and included both
in-hospital fatalities and out of hospital fatalities.Strengths and limitations
One of the main strengths of this study was the size of the
dataset; we studied a whole population of 5.1 million
people over a 27 year period. This study used discharge
codes to identify admissions with asthma in the principal
position. The Scottish Morbidity Record Scheme is audited
routinely and has been shown to be an accurate record of
the discharge and diagnosis for each admission.15 A report
from 2004 to 2006 shows the accuracy of the SMR01 data-
base is approximately 88% for the primary diagnosis for
inpatients,15 previous publication has shown an accuracy of
* Adjusted for age, sex, deprivation, year of admission, admission type and comorbidities
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Figure 1 Adjusted* and unadjusted odds ratios case-fatality up to 30 days after asthma admission for study period.
1176 N.J. Roberts et al.89.3% in 1996e1997 for main diagnoses.25 The aim of this
study was to identify case-fatality after a hospital admis-
sion for asthma; to ensure robustness we used asthma in
the principal diagnostic position to identify asthma admis-
sions. Sensitivity analyses were carried out to identify the
proportion of hospitalisations with asthma in a secondary
position, including shortness of breath, respiratory in-
fections and COPD in the principal position. In total, only an
additional 17 702 admissions were identified, of which
COPD were 6.3%. We acknowledge that we do not have
access to clinical and therapeutic data from these
hospitalisations.
This study described the likelihood of 30 day case-
fatality following an asthma hospitalisation according to
age group, sex, socioeconomic deprivation and comorbid-
ities using routinely collected linked morbidity and mor-
tality data. Despite significant improvements in the
delivery of treatment and care for asthma, this study has
shown a case-fatality level of 0.9% with 1000 deaths over
the study period. Asthma mortality is relatively rare in
comparison to other chronic conditions and the strength of
this study lie in the large number of hospitalisations studied
in contrast to other smaller studies of hospitalisations with
linked primary care data.
The delivery of respiratory care has changed signifi-
cantly over the last 30 years, which may also have had an
impact on hospital admissions including the introduction ofevidence-based clinical respiratory guidelines in the early
1990s,23,24,26 and increasing emphasis on self-manage-
ment.27 Earlier studies have suggested that the overall
reduction in asthma morbidity seen between the late 1960s
and mid 1980s reflects better care, and better use of
existing therapies.28 From the late 1980s there has been
increased use of inhaled corticosteroid therapy world-
wide,29,30 and increasing evidence that inhaled corticoste-
roids reduce the risk of asthma mortality.31e33 These
factors may have contributed to the trend towards a
reduction in the odds of 30 day case-fatality observed in our
study since the mid-1990s.Conclusions
Case-fatality at 30 days following a hospitalisation for
asthma in Scotland is less than 1%. This is comparable to
case-fatality reported in other parts of the UK. The likeli-
hood of death 30 days following an asthma admission
increased with age group and was associated with co-
morbid respiratory failure, cancer, renal failure, cor pul-
monale, coronary heart disease, and respiratory infection.
Case-fatality at 30 days declined through the study period.
Consistent with other studies, this decline may be in part
due to improved guidelines and protocols, and disease
management for asthma over the last 30 years.
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